4d pharma (LSE:DDDD) Other Long-Term Liabilities : £5.00 Mil (As of Dec. 2021)

View and export this data going back to 2014. Start your Free Trial

What is 4d pharma Other Long-Term Liabilities?

4d pharma's other long-term liabilities for the quarter that ended in Dec. 2021 was £5.00 Mil.

4d pharma's quarterly other long-term liabilities increased from Dec. 2020 (£0.01 Mil) to Jun. 2021 (£11.52 Mil) but then declined from Jun. 2021 (£11.52 Mil) to Dec. 2021 (£5.00 Mil).

4d pharma's annual other long-term liabilities declined from Dec. 2019 (£1.47 Mil) to Dec. 2020 (£0.01 Mil) but then increased from Dec. 2020 (£0.01 Mil) to Dec. 2021 (£5.00 Mil).

4d pharma Other Long-Term Liabilities Historical Data

The historical data trend for 4d pharma's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

4d pharma Other Long-Term Liabilities Chart

4d pharma Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Other Long-Term Liabilities

Get a 7-Day Free Trial

4d pharma Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21
Other Long-Term Liabilities	Get a 7-Day Free Trial											-	-	-	-	-

4d pharma Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

4d pharma Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of 4d pharma's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

4d pharma (LSE:DDDD) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 4d pharma PLC (LSE:DDDD) » Definitions » Other Long-Term Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

9 Bond Court, Fifth Floor, Leeds, GBR, LS1 2JZ

Website

https://www.4dpharmaplc.com

4d pharma PLC and its subsidiaries are in the business of research and development and production of live biotherapeutic products. The company develops biotherapeutic products for diseases such as cancer, asthma, autism, and autoimmune conditions such as arthritis and multiple sclerosis. Its developing science includes Live biotherapeutics, Microbiome, MicroRx, MicroDx, and others.

4d pharma (LSE:DDDD) Headlines

No Headlines